Jong Gwang Kim

8.7k total citations
203 papers, 3.4k citations indexed

About

Jong Gwang Kim is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Jong Gwang Kim has authored 203 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 107 papers in Oncology, 64 papers in Pulmonary and Respiratory Medicine and 42 papers in Surgery. Recurrent topics in Jong Gwang Kim's work include Gastric Cancer Management and Outcomes (53 papers), Colorectal Cancer Treatments and Studies (40 papers) and Hematopoietic Stem Cell Transplantation (25 papers). Jong Gwang Kim is often cited by papers focused on Gastric Cancer Management and Outcomes (53 papers), Colorectal Cancer Treatments and Studies (40 papers) and Hematopoietic Stem Cell Transplantation (25 papers). Jong Gwang Kim collaborates with scholars based in South Korea, United States and Taiwan. Jong Gwang Kim's co-authors include Yee Soo Chae, Sang Kyun Sohn, Gyu‐Seog Choi, Byung Woog Kang, Soo Jung Lee, Jun Seok Park, Kyu Bo Lee, Jin Ho Baek, Jang Soo Suh and Joon Ho Moon and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Jong Gwang Kim

195 papers receiving 3.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jong Gwang Kim South Korea 33 1.5k 1.1k 769 599 592 203 3.4k
Gurkamal Chatta United States 34 1.3k 0.9× 1.2k 1.1× 1.0k 1.3× 521 0.9× 270 0.5× 143 3.5k
Laurent Guy France 42 820 0.6× 1.5k 1.4× 1.3k 1.7× 1.3k 2.1× 645 1.1× 153 4.5k
Ishmael Jaiyesimi United States 21 1.3k 0.9× 632 0.6× 784 1.0× 277 0.5× 236 0.4× 119 3.1k
Jean‐Paul Guastalla France 31 2.2k 1.5× 621 0.6× 495 0.6× 521 0.9× 285 0.5× 109 3.7k
Yuxiang Ma China 32 2.2k 1.5× 804 0.7× 1.2k 1.6× 401 0.7× 330 0.6× 166 3.8k
Brian Kabat United States 22 2.0k 1.4× 1.1k 1.0× 413 0.5× 334 0.6× 1.7k 2.8× 48 3.5k
Renuka Iyer United States 31 1.5k 1.0× 573 0.5× 753 1.0× 755 1.3× 337 0.6× 178 3.0k
Samuel A. Jacobs United States 25 1.4k 1.0× 620 0.6× 450 0.6× 179 0.3× 753 1.3× 143 2.9k
N. Tubiana-Mathieu France 30 2.0k 1.4× 436 0.4× 644 0.8× 338 0.6× 495 0.8× 166 3.2k
Ralph Levitt United States 27 2.1k 1.4× 670 0.6× 892 1.2× 682 1.1× 407 0.7× 67 3.6k

Countries citing papers authored by Jong Gwang Kim

Since Specialization
Citations

This map shows the geographic impact of Jong Gwang Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jong Gwang Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jong Gwang Kim more than expected).

Fields of papers citing papers by Jong Gwang Kim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jong Gwang Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jong Gwang Kim. The network helps show where Jong Gwang Kim may publish in the future.

Co-authorship network of co-authors of Jong Gwang Kim

This figure shows the co-authorship network connecting the top 25 collaborators of Jong Gwang Kim. A scholar is included among the top collaborators of Jong Gwang Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jong Gwang Kim. Jong Gwang Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Lee, Dong Hyeon, Hee Jeong Cho, Sang Kyun Sohn, et al.. (2023). Circulating-tumor DNA Assessment in Diffuse Large B-cell Lymphoma to Determine Up-front Stem Cell Transplantation: A Pilot Study. In Vivo. 38(1). 372–379. 2 indexed citations
3.
Yang, Tsai‐Sheng, Hong‐Hwa Chen, Tae Won Kim, et al.. (2023). Prospective, open‐label, and observational study of cetuximab for metastatic colorectal carcinoma: The OPTIM1SE study. Asia-Pacific Journal of Clinical Oncology. 19(6). 672–680.
4.
Lee, Kyung Ha, Soo Yeun Park, Seung Ho Song, et al.. (2023). Short-term outcomes of Early versus conventional adjuvant chemotherapy in stage III colon cancer: randomized clinical trial. BJS Open. 7(4). 2 indexed citations
5.
6.
Park, Soo Yeun, Jun Seok Park, Hye Jin Kim, et al.. (2022). Oncological impact of intraperitoneal chemotherapy after cytoreductive surgery for patients with colorectal peritoneal metastasis: A bi‐institutional retrospective analysis. Journal of Surgical Oncology. 127(4). 668–677. 2 indexed citations
7.
Kim, Hyung‐Don, Jong Seok Lee, Young Soo Park, et al.. (2022). Determinants of clinical outcomes of gastric cancer patients treated with neoadjuvant chemotherapy: a sub-analysis of the PRODIGY study. Gastric Cancer. 25(6). 1039–1049. 4 indexed citations
8.
9.
Oh, Sung Yong, Suee Lee, Jeeyun Lee, et al.. (2018). Safety and efficacy of trastuzumab administered as a 30-min infusion in patients with HER2-positive advanced gastric cancer. Cancer Chemotherapy and Pharmacology. 83(3). 501–508. 7 indexed citations
10.
Kang, Sun‐Hee, Yee Soo Chae, Soo Jung Lee, et al.. (2015). Aquaporin 3 Expression Predicts Survival in Patients with HER2-positive Early Breast Cancer.. PubMed. 35(5). 2775–82. 34 indexed citations
11.
Kang, Byung Woog, Jong Gwang Kim, Soo Jung Lee, et al.. (2015). Expression of Aquaporin-1, Aquaporin-3, and Aquaporin-5 Correlates with Nodal Metastasis in Colon Cancer. Oncology. 88(6). 369–376. 71 indexed citations
12.
Kang, Byung Woog, Sang Kyun Sohn, Joon Ho Moon, et al.. (2014). Clinical features and treatment outcomes in patients with mantle cell lymphoma in Korea: Study by the Consortium for Improving Survival of Lymphoma. Blood Research. 49(1). 15–15. 15 indexed citations
13.
Lee, Soo Jung, Yee Soo Chae, Jong Gwang Kim, et al.. (2013). AQP5 Expression Predicts Survival in Patients with Early Breast Cancer. Annals of Surgical Oncology. 21(2). 375–383. 62 indexed citations
14.
Yeo, Winnie, Sang Kyun Sohn, Jong Gwang Kim, et al.. (2009). Interaction between BCL2 and Interleukin-10 Gene Polymorphisms Alter Outcomes of Diffuse Large B-Cell Lymphoma following Rituximab Plus CHOP Chemotherapy. Clinical Cancer Research. 15(6). 2107–2115. 26 indexed citations
15.
Lee, Soo Jung, Byung Min Ahn, Jong Gwang Kim, et al.. (2009). Definitive Chemoradiotherapy with Capecitabine and Cisplatin in Patients with Esophageal Cancer: A Pilot Study. Journal of Korean Medical Science. 24(1). 120–120. 9 indexed citations
16.
Cho, Yoon Young, Jong Gwang Kim, Yee Soo Chae, et al.. (2008). Salvage treatments with all-trans retinoic acid and arsenic trioxide-based regimens in acute promyelocytic leukemia. The Korean Journal of Internal Medicine. 74(6). 596–604. 2 indexed citations
17.
Kim, Jong Gwang, Sang Kyun Sohn, Yee Soo Chae, et al.. (2008). TP53 codon 72 polymorphism associated with prognosis in patients with advanced gastric cancer treated with paclitaxel and cisplatin. Cancer Chemotherapy and Pharmacology. 64(2). 355–360. 36 indexed citations
18.
Kim, Dong Hwan, Dong Il Won, Sang Kyun Sohn, et al.. (2006). Survival Benefit of Asymptomatic Cytomegalovirus Reactivation after HLA-Identical Allogeneic Peripheral Blood Stem Cell Transplantation. Transplantation. 81(1). 101–108. 7 indexed citations
19.
Kim, Jong Gwang, Sang Kyun Sohn, Yee Soo Chae, et al.. (2005). CHOP plus etoposide and gemcitabine (CHOP-EG) as front-line chemotherapy for patients with peripheral T cell lymphomas. Cancer Chemotherapy and Pharmacology. 58(1). 35–39. 45 indexed citations
20.
Sohn, Sang Kyun, Jin Tae Jung, Dong Hwan Kim, et al.. (2003). Prognostic significance of bcl‐2, bax, and p53 expression in diffuse large B‐cell lymphoma. American Journal of Hematology. 73(2). 101–107. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gurkamal Chatta Breakdown of academic impact, for papers by Laurent Guy Breakdown of academic impact, for papers by Ishmael Jaiyesimi Breakdown of academic impact, for papers by Jean‐Paul Guastalla Breakdown of academic impact, for papers by Yuxiang Ma Breakdown of academic impact, for papers by Brian Kabat Breakdown of academic impact, for papers by Renuka Iyer Breakdown of academic impact, for papers by Samuel A. Jacobs Breakdown of academic impact, for papers by N. Tubiana-Mathieu Breakdown of academic impact, for papers by Ralph Levitt
Rankless by CCL
2026